Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient

The PI3K–Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability

(2010) Hyun-Ja Nam et al.   CARCINOGENESIS

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

(2009) Kuan-Ting Kuo et al.   AMERICAN JOURNAL OF PATHOLOGY

An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway

(2009) Sohei Yamamoto et al.   VIRCHOWS ARCHIV

HGF/MET Signaling in Ovarian Cancer

(2008) Hong Zhou et al.   CURRENT MOLECULAR MEDICINE

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

(2008) Hiroaki Nitta et al.   Diagnostic Pathology

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers

(2008) John K. Chan et al.   GYNECOLOGIC ONCOLOGY